Christian Beltinger
Overview
Explore the profile of Christian Beltinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorneburg C, Galiger C, Stadler G, Westhoff M, Rasche V, Barth T, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136322
Increased expression of BIRC5/survivin, a crucial regulator of the mitotic spindle checkpoint, is associated with poor prognosis in neuroblastoma (NB), the most common extracranial tumor of childhood. Transcriptional inhibitors of...
2.
Galiger C, Zohora F, Dorneburg C, Tews D, Debatin K, Beltinger C
BMC Cancer
. 2023 Nov;
23(1):1148.
PMID: 38007466
Background: Neuroblastoma (NB), the most common extracranial solid malignancy in children, carries a poor prognosis in high-risk disease, thus requiring novel therapeutic approaches. Survivin is overexpressed in NB, has pro-mitotic...
3.
Riehl L, Mulaw M, Kneer K, Beer M, Beer A, Barth T, et al.
Cancer Rep (Hoboken)
. 2022 Jul;
6(1):e1687.
PMID: 35899825
Background: The utility for liquid biopsy of tumor-associated circulating single-nucleotide variants, as opposed to mutations, of the mitochondrial (mt) and nuclear genomes in neuroblastoma (NB) is unknown. Procedure: Variants of...
4.
Galiger C, Dahlhaus M, Vitek M, Debatin K, Beltinger C
Front Oncol
. 2022 Jul;
12:744984.
PMID: 35814385
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood and has a poor prognosis in high-risk cases, requiring novel therapies. Pathways that depend on phospho-signaling maintain the aggressiveness...
5.
Laut A, Dorneburg C, Furstberger A, Barth T, Kestler H, Debatin K, et al.
Oncogene
. 2021 Nov;
41(5):622-633.
PMID: 34789839
CHD5, a tumor suppressor at 1p36, is frequently lost or silenced in poor prognosis neuroblastoma (NB) and many adult cancers. The role of CHD5 in metastasis is unknown. We confirm...
6.
Peschmann A, Beer M, Ammann B, Dreyhaupt J, Kneer K, Beer A, et al.
Eur Radiol Exp
. 2019 Feb;
3(1):6.
PMID: 30701332
Background: Quantitative diffusion-weighted imaging (DWI) probes into tissue microstructure in solid tumours. In this retrospective ethically approved study, we investigated DWI as a potential non-invasive predictor of tumour dignity and...
7.
8.
Dorneburg C, Fischer M, Barth T, Mueller-Klieser W, Hero B, Gecht J, et al.
Clin Cancer Res
. 2018 Jun;
24(22):5772-5783.
PMID: 29925504
To investigate whether lactate dehydrogenase A (LDHA), an important component of the LDH tetramer crucial for aerobic glycolysis, is associated with patient outcome and constitutes a therapeutic target in neuroblastoma...
9.
Xu C, Goss A, Dorneburg C, Debatin K, Wei J, Beltinger C
Oncolytic Virother
. 2018 May;
7:37-41.
PMID: 29750140
Background: Attenuated oncolytic measles virus (OMV) is a promising antitumor agent in early-phase clinical trials. However, pre-existing immunity against measles might be a hurdle for OMV therapy. Methods: OMV was...
10.
Chen A, Zhang Y, Meng G, Jiang D, Zhang H, Zheng M, et al.
Sci Rep
. 2017 Jul;
7(1):5170.
PMID: 28701757
There is an urgent need for novel effective treatment for hepatocellular carcinoma (HCC). Oncolytic viruses (OVs) not only directly lyse malignant cells, but also induce potent antitumour immune responses. The...